Clover Health Investments
CLOV
168 hedge funds and large institutions have $353M invested in Clover Health Investments in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 31 closing their positions.
58% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 33
32% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 31
19% more call options, than puts
Call options by funds: $31M | Put options by funds: $26M
4% more funds holding
Funds holding: 161 → 168 (+7)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
13.07% less ownership
Funds ownership: 39.38% → 26.32% (-13%)
27% less capital invested
Capital invested by funds: $484M → $353M (-$131M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$9.71M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.56M |
| 3 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$2.8M |
| 4 |
Renaissance Technologies
New York
|
+$2.77M |
| 5 |
Goldman Sachs
New York
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
Greenoaks Capital Partners
Orinda,
California
|
-$92.4M |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$19.7M |
| 3 |
Two Sigma Investments
New York
|
-$9.85M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$8.11M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.77M |
CLOV Hedge Fund Activity: Q1 2022 in Review
168 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q1 2022, worth a combined $353M — down 27% from $484M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new CLOV positions and 31 closed out — a net gain of 10 holders — while 52 added to existing stakes and 33 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $9.71M. The largest seller was Greenoaks Capital Partners, exiting entirely with an estimated $92.4M sold.
- 168 institutional investors held Clover Health Investments (CLOV) as of Q1 2022, up from 161 in Q4 2021.
- Funds reported $353M of Clover Health Investments stock for Q1 2022, down 27% quarter-over-quarter.
- 41 funds opened new Clover Health Investments positions in Q1 2022 and 31 closed out, a net change of +10 holders.
- The largest Clover Health Investments buyer in Q1 2022 was D.E. Shaw & Co, an estimated $9.71M added.
- The largest Clover Health Investments seller in Q1 2022 was Greenoaks Capital Partners, an estimated $92.4M sold.
Based on aggregated 13F filings for Q1 2022.